GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
Open Access
- 1 January 2012
- journal article
- review article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 10 (1) , 26
Abstract
Several protocols are actually available for in Vitro Fertilization and Embryo Transfer. The review summarizes the main differences and the clinic characteristics of the protocols in use with GnRH agonists and GnRH antagonists by emphasizing the major outcomes and hormonal changes associated with each protocol. The majority of randomized clinical trials clearly shows that in “in Vitro” Fertilization and Embryo Transfer, the combination of exogenous Gonadotropin plus a Gonadotropin Releasing Hormone (GnRH) agonist, which is able to suppress pituitary FSH and LH secretion, is associated with increased pregnancy rate as compared with the use of gonadotropins without a GnRH agonist. Protocols with GnRH antagonists are effective in preventing a premature rise of LH and induce a shorter and more cost-effective ovarian stimulation compared to the long agonist protocol. However, a different synchronization of follicular recruitment and growth occurs with GnRH agonists than with GnRH antagonists. Future developments have to be focused on timing of the administration of GnRH antagonists, by giving a great attention to new strategies of stimulation in patients in which radio-chemotherapy cycles are needed.Keywords
This publication has 46 references indexed in Scilit:
- GnRH agonist for triggering of final oocyte maturation: time for a change of practice?Human Reproduction Update, 2011
- Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKTArchives of Gynecology and Obstetrics, 2011
- Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysisFertility and Sterility, 2010
- GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulationReproductive BioMedicine Online, 2010
- Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologiesFertility and Sterility, 2005
- Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilizationFertility and Sterility, 2004
- Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization–embryo transfer patientsFertility and Sterility, 2004
- Relationship between gonadotropin releasing hormone agonist dosage andin vitrofertilization outcomeGynecological Endocrinology, 2004
- Gonadotropin-releasing-hormone-receptor antagonistsThe Lancet, 2001
- NEVER ON A SUNDAY: PROGRAMMING FOR IVF-ET AND GIFTThe Lancet, 1987